glp-1 and menopause If you're in perimenopause or curious about GLP-1s, you're not alone. ⁠ ⁠ Here's what to consider:⁠ ⁠ 🍽️ Your appetite may drop and while that can *feel* like a GLP-1s and the Menopause: What

Tirzepatide is a promising drug withdual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor activation that has revolutionized the treatment of type 2 diabetesmellitus (T2DM) as an adjunct to ...

SUPPORTS MIND-BODY CONNECTION & HABIT FORMATION: Designed to help reinforce healthy routines by supporting clearer hunger cues and more intentional eating patterns when used alongside a healthy lifestyle

Obesity is a chronic disease associated with increased risk of obesity-related complications and mortality

Engineering new ligands that specifically target multiple G protein-coupled receptors with desired activity profiles requires time-consuming and expensive cycles of design-make-test-analyse work

Designed to complement your GLP-1 journey

GLP-1-based therapies helped adults with overweight or obesity lose weight mainly by reducing fat mass and visceral adipose tissue, while lean body mass losses were generally modest